GAMBACORTI PASSERINI CARLO

Position:
Role
Full Professor  
Academic disciplines
Blood Diseases (MEDS-09/B)
Scientific-Disciplinary Group:
BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY (06/MEDS-09)
Office phone
Room:
  • U08, Floor: 4, Room: 4-12
  • U08, Floor: 4, Room: 4041

Publications

  • Fontana, D., Zambrotta, G., Scannella, A., Piazza, R., Gambacorti-Passerini, C. (2024). Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape. ANNALS OF HEMATOLOGY [10.1007/s00277-024-05649-4]. Detail

  • Poggio, P., Rocca, S., Fusella, F., Ferretti, R., Ala, U., D'Anna, F., et al. (2024). miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia. SCIENTIFIC REPORTS, 14(1) [10.1038/s41598-024-65404-7]. Detail

  • Manghisi, B., Borin, L., Monaco, M., Sacco, G., Antolini, L., Mantegazza, R., et al. (2024). Communicating the diagnosis of a hematological neoplastic disease to patients’ minor children: a multicenter prospective study. THE ONCOLOGIST [10.1093/oncolo/oyae104]. Detail

  • Rindone, G., Rossi, M., Sabbatini, F., Columpsi, P., Dalu, D., Fasola, C., et al. (2024). CNS relapse risk in HIV-positive patients affected by DLBCL and HGBL – a retrospective study of the musthal cohort. In Abstracts from the 16° Italian Conference on AIDS and Antiviral Research (pp.61-62) [10.1136/sextrans-icar-2024.57]. Detail

  • Zappaterra, A., Civettini, I., Cafro, A., Pezzetti, L., Pierini, S., Anghilieri, M., et al. (2024). Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients. BLOOD TRANSFUSION, 22(4), 328-337 [10.2450/BloodTransfus.667]. Detail

Research projects

Bioinformatic integration of clonal hierarchies, mutational and functional landscapes of tumors to build a theragnostic tool in cancer treatment
Year: 2021
Call: FAQC 2021 - terza finestra
Grantors: Università degli Studi di MILANO-BICOCCA
FANTOM - Future of ALCL: Novel Therapies, Origins, Bio-Markers and Mechanism of resistance
Year: 2021
Call: MSCA Doctoral Networks 2021
Grantors: EUROPEAN COMMISSION
Molecular pathogenesis of atypical CML: Converting NGS-obtained data into therapeutically relevant information - V annualità
Year: 2021
Call: 2017-005 - Call for Proposals 2017 Investigator Grant (IG)
Grantors: FONDAZIONE AIRC
Molecular pathogenesis of atypical CML: Converting NGS-obtained data into therapeutically relevant information - IV annualità
Year: 2020
Call: 2017-005 - Call for Proposals 2017 Investigator Grant (IG)
Grantors: FONDAZIONE AIRC
HARMONY PLUS-Clonal hierarchy in CML
Year: 2019
Call: Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
Grantors: EUROPEAN COMMISSION

Awards

Awards

  • ABILITAZIONE SCIENTIFICA NAZIONALE A PROFESSORE DI I FASCIA, SSD MED015, MIUR, 2013

Research and teaching assignments

  • Professore a contratto - Professor of Oncology and hematology, Canada research Chair, Dept of Oncology, Jewish General Hospital, Montreal, Canadà - McGill University, 2003 - 2008

Congresses/Conferences

  • Program chair - 5th ERIA meeting, "20 year of anniversary of the discovery of ALK", 2014